AMY BRETT: Open Payments
NPI 1437898921 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 38 payments from 20 companies in 2025. Trend: 2023 $473 · 2024 $783 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $128 |
| Genentech USA, Inc. | 3 | $73 |
| Genmab U.S., Inc. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 4 | $66 |
| Janssen Biotech, Inc. | 2 | $61 |
| PFIZER INC. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
Products named: JAKAFI, KISQALI, Epkinly, ENHERTU, Polivy, Nubeqa, CARVYKTI, OPDIVO.
Industry payments across DE — which companies pay providers there.
